Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalyst Pharmaceutical Partners, Inc. (CPRX)  
$14.89 0.21 (1.43%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 103,650,000
Market Cap: 1.54(B)
Last Volume: 772,336 Avg Vol: 1,689,102
52 Week Range: $11.5 - $17.51
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  604
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 50,000 304,000 330,151 4,223,516
Total Sell Value $803,000 $4,338,050 $4,684,028 $62,649,148
Total People Sold 2 6 7 12
Total Sell Transactions 2 8 9 53
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 312
  Page 6 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2022-11-11 4 S $15.46 $2,241,382 D/D (139,017) 0 -12%     
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2022-11-11 4 OE $2.24 $385,798 D/D 139,017 19,017     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2022-11-11 4 S $16.24 $238,103 D/D (14,666) 11,096 -12%     
   Grande Alicia VP, Treasurer and CFO   •       –      –    2022-09-23 4 S $11.90 $713,940 D/D (60,000) 207,442 -34%     
   Grande Alicia VP, Treasurer and CFO   •       –      –    2022-09-16 4 S $13.50 $1,214,640 D/D (90,000) 267,442 -17%     
   Sundaram Preethi Chief Strategy Officer   •       –      –    2022-09-15 4 S $14.49 $263,921 D/D (18,214) 0 -14%     
   Sundaram Preethi Chief Strategy Officer   •       –      –    2022-09-15 4 OE $5.49 $99,995 D/D 18,214 18,214     -
   Ingenito Gary Chief Medical & Reg. Officer   •       –      –    2022-09-14 4 S $15.65 $2,241,459 D/D (143,000) 22,053 -3%     
   Ingenito Gary Chief Medical & Reg. Officer   •       –      –    2022-09-14 4 OE $4.01 $628,870 D/D 143,000 110,053     -
   Grande Alicia VP, Treasurer and CFO   •       –      –    2022-09-14 4 S $15.57 $778,650 D/D (50,000) 357,442 -3%     
   Coelho Philip H Director   –       •      –    2022-09-14 4 S $15.75 $315,000 D/D (20,000) 249,553 -3%     
   Denkhaus Donald A Director   –       •      –    2022-09-14 4 S $15.34 $306,800 D/D (20,000) 297,666 -3%     
   Mcenany Patrick J President and CEO   •       •      –    2022-09-14 4 S $15.41 $14,594,684 D/D (946,846) 3,902,606 -3%     
   Coelho Philip H Director   –       •      –    2022-09-13 4 S $15.70 $157,000 D/D (10,000) 269,553 -9%     
   Mcenany Patrick J President and CEO   •       •      –    2022-09-13 4 S $15.33 $1,238,047 D/D (80,765) 4,849,452 -9%     
   Miller Steve Chief Operating Officer   •       –      –    2022-09-13 4 S $16.85 $1,824,367 D/D (107,933) 653,791 -9%     
   Grande Alicia VP, Treasurer and CFO   •       –      –    2022-08-29 4 S $14.14 $809,560 D/D (57,000) 407,442 -40%     
   Grande Alicia VP, Treasurer and CFO   •       –      –    2022-08-26 4 S $14.40 $159,768 D/D (11,095) 464,442 -36%     
   Daly Richard J Director   –       •      –    2022-08-24 4 OE $2.53 $101,200 D/D 40,000 92,666     -
   Tierney David S Director   –       •      –    2022-08-22 4 S $14.16 $283,180 D/D (20,000) 308,207 -26%     
   Tierney David S Director   –       •      –    2022-08-22 4 OE $2.53 $50,600 D/D 20,000 328,207     -
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2022-08-19 4 S $14.05 $198,667 D/D (14,140) 0 -32%     
   Mcenany Patrick J President and CEO   •       •      –    2022-08-19 4 S $14.10 $1,762,425 D/D (125,000) 4,930,217 -32%     
   Mcenany Patrick J President and CEO   •       •      –    2022-08-19 4 OE $2.53 $316,250 D/D 125,000 5,055,217     -
   Grande Alicia VP, Treasurer and CFO   •       –      –    2022-08-18 4 S $13.70 $263,848 D/D (19,259) 475,537 -33%     
  312 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us